Corrigendum

doi:10.2174/1568026043387098

Abstract

J. Balzarini, Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1, Curr. Top. Med. Chem. 2004, 4, 921-944. The correct generic name for TMC125 listed in the abstract, Table 1 and Figure 1 is etravirine, and not dapivirine as listed.

« Previous

Download Options

Rights & Permissions Print Cite

Current Topics in Medicinal Chemistry

Title: Corrigendum

Volume: 4 Issue: 16

Abstract: J. Balzarini, Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1, Curr. Top. Med. Chem. 2004, 4, 921-944. The correct generic name for TMC125 listed in the abstract, Table 1 and Figure 1 is etravirine, and not dapivirine as listed.